Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection

被引：25

作者：

Fanouriakis, Antonis ^{[1
]}

Vassilopoulos, Dimitrios ^{[2
]}

Repa, Argyro ^{[1
]}

Boumpas, Dimitrios T. ^{[3
]}

Sidiropoulos, Prodromos ^{[1
]}

机构：

[1] Univ Hosp Heraklion, Dept Rheumatol Clin Immunol & Allergy, Iraklion 71110, Crete, Greece

[2] Univ Athens, Sch Med, Dept Med 3, Hippokrat Gen Hosp, GR-11527 Athens, Greece

[3] Univ Athens, Sch Med, Dept Med 3, Sotiria Gen Hosp, GR-11527 Athens, Greece

来源：

RHEUMATOLOGY | 2014年 / 53卷 / 01期

关键词：

RHEUMATOID-ARTHRITIS PATIENTS; SAFETY; DISEASES; THERAPY;

D O I：

10.1093/rheumatology/ket221

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：195 / 196

页数：2

共 9 条

[1] Safety of Tumor Necrosis Factor α Blockers in Hepatitis B Virus Occult Carriers (Hepatitis B Surface Antigen Negative/Anti-Hepatitis B Core Antigen Positive) With Rheumatic Diseases [J].

Caporali, R. ;

Bobbio-Pallavicini, F. ;

Atzeni, F. ;

Sakellariou, G. ;

Caprioli, M. ;

Montecucco, C. ;

Sarzi-Puttini, P. .

ARTHRITIS CARE & RESEARCH, 2010, 62 (06) :749-754

[2] Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients [J].

Charpin, Caroline ;

Guis, Sandrine ;

Colson, Philippe ;

Borentain, Patrick ;

Mattei, Jean-Pierre ;

Alcaraz, Patrice ;

Balandraud, Nathalie ;

Thomachot, Benoit ;

Roudier, Jean ;

Gerolami, Rene .

ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)

[3] Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept [J].

Germanidis, Georgios ;

Hytiroglou, Prodromos ;

Zakalka, Marina ;

Settas, Loukas .

JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1420-1421

[4] Safety and Efficacy of Abatacept in Eight Rheumatoid Arthritis Patients With Chronic Hepatitis B [J].

Kim, Paul S. ;

Ho, Gerald Y. ;

Prete, Pamela E. ;

Furst, Daniel E. .

ARTHRITIS CARE & RESEARCH, 2012, 64 (08) :1265-1268

[5] Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy [J].

Lan, Joung-Liang ;

Chen, Yi-Ming ;

Hsieh, Tsu-Yi ;

Chen, Yi-Hsing ;

Hsieh, Chia-Wei ;

Chen, Der-Yuan ;

Yang, Sheng-Shun .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1719-1725

[6] Drug Insight: abatacept for the treatment of rheumatoid arthritis [J].

Ruderman, Eric M. ;

Pope, Richard M. .

NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (12) :654-660

[7] Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection [J].

Vassilopoulos, D. ;

Apostolopoulou, A. ;

Hadziyannis, E. ;

Papatheodoridis, G. V. ;

Manolakopoulos, S. ;

Koskinas, J. ;

Manesis, E. K. ;

Archimandritis, A. I. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) :1352-1355

[8] Management of rheumatic disease with comorbid HBV or HCV infection [J].

Vassilopoulos, Dimitrios ;

Calabrese, Leonard H. .

NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (06) :348-357

[9] Let the fog be lifted: screening for hepatitis B virus before biological therapy [J].

Winthrop, Kevin L. ;

Calabrese, Leonard H. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1701-1703

← 1 →